VINEETLABNSEVineet Laboratories LimitedHighNeutral
Announced Wed, 14 May · 18:24 IST

Vineet Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2025 -The Board of Directors of the company in its meeting held today i.e., on Wednesday, May 14, 2025 has approved the following, subject to the approval of the shareholders:1. the appointment of Mr. Rajesh Kumar Kathulla (DIN: 05349717) as an Additional Director, designated as Whole Time Director of the Company effective May 14, 2025; 2. the increase of Authorised Share Capital from the existing ₨.10,81,00,000/- (Rupees Ten Crore Eighty one Lakh Only) consisting of 1,08,10,000 (One Crore Eight Lakh Ten Thousand Only) equity shares of face value ₨.10.00/- each to ₨ 20,00,00,000/- (Rupees Twenty Crore Only) consisting of 2,00,00,000 (Two Crore Only) equity shares of face value ₨.10.00/- each, and the consequent alteration of Clause V of the Memorandum of Association of the Company.

Management Changes View source PDF

VINEETLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Directors of Vineet Laboratories, at its meeting on May 14, 2025, approved two key items subject to shareholder approval. First, Mr. Rajesh Kumar Kathulla (DIN: 05349717) has been appointed as an Additional Director designated as Whole Time Director, effective the same day. Second, the company proposes to increase its Authorised Share Capital from ₹10.81 crore (1,08,10,000 equity shares of ₹10 each) to ₹20 crore (2,00,00,000 equity shares of ₹10 each), nearly doubling the authorised limit. This will also require an amendment to Clause V of the Memorandum of Association. Both decisions are pending shareholder approval.

Likely market impact

Shareholders will get a vote on the new director appointment and the proposed capital expansion, which gives the company more headroom to issue fresh shares in the future. The near-doubling of authorised capital could be a precursor to a fundraising round or stock split, which may dilute existing holdings if any new shares are eventually issued.